$IVZ
Invesco Ltd. Stock $ivz

$ivz Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-Q Financial Statement

#000091420823000338 Filed on May 03, 2023

Income Statement

Concept	2023 Q1
Revenue	$1.418B
YoY Change	-12.96%
Cost Of Revenue	$455.1M
YoY Change	-11.22%
Gross Profit	$963.1M
YoY Change	-13.76%
Gross Profit Margin	67.91%
Selling, General & Admin	$100.7M
YoY Change	-18.72%
% of Gross Profit	10.46%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$46.80M
YoY Change	-5.45%
% of Gross Profit	4.86%
Operating Expenses	$1.209B
YoY Change	-3.44%
Operating Profit	$209.5M
YoY Change	-44.53%
Interest Expense	$18.00M
YoY Change	-22.41%
% of Operating Profit	8.59%
Other Income/Expense, Net	$27.40M
YoY Change	-160.22%
Pretax Income	$235.7M
YoY Change	-26.41%
Income Tax	$69.90M
% Of Pretax Income	29.66%
Net Earnings	$145.0M
YoY Change	-26.66%
Net Earnings / Revenue	10.22%
Basic Earnings Per Share	$0.32
Diluted Earnings Per Share	$0.32
COMMON SHARES
Basic Shares Outstanding	454.8M shares
Diluted Shares Outstanding	458.9M shares

Balance Sheet

Concept	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$889.0M
YoY Change	-32.12%
Cash & Equivalents	$889.0M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables	$805.7M
Other Receivables	$0.00
Total Short-Term Assets	$1.695B
YoY Change	-17.97%
LONG-TERM ASSETS
Property, Plant & Equipment	$572.6M
YoY Change	14.61%
Goodwill	$8.603B
YoY Change	-2.76%
Intangibles	$7.131B
YoY Change	-1.05%
Long-Term Investments	$658.0M
YoY Change	5.5%
Other Assets
YoY Change
Total Long-Term Assets	$28.04B
YoY Change	-5.87%
TOTAL ASSETS
Total Short-Term Assets	$1.695B
Total Long-Term Assets	$28.04B
Total Assets	$29.73B
YoY Change	-6.66%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.466B
YoY Change	15.3%
Accrued Expenses	$434.7M
YoY Change	-12.25%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.549B
YoY Change	-25.66%
LONG-TERM LIABILITIES
Long-Term Debt	$8.262B
YoY Change	-9.9%
Other Long-Term Liabilities	$420.8M
YoY Change	-44.86%
Total Long-Term Liabilities	$8.683B
YoY Change	-12.58%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.549B
Total Long-Term Liabilities	$8.683B
Total Liabilities	$12.92B
YoY Change	-14.22%
SHAREHOLDERS EQUITY
Retained Earnings	$7.578B
YoY Change	3.98%
Common Stock	$7.526B
YoY Change	-1.75%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$2.888B
YoY Change	-6.99%
Treasury Stock Shares
Shareholders Equity	$15.34B
YoY Change
Total Liabilities & Shareholders Equity	$29.73B
YoY Change	-6.66%

Cashflow Statement

Concept	2023 Q1
OPERATING ACTIVITIES
Net Income	$145.0M
YoY Change	-26.66%
Depreciation, Depletion And Amortization	$46.80M
YoY Change	-5.45%
Cash From Operating Activities	-$98.90M
YoY Change	-73.65%
INVESTING ACTIVITIES
Capital Expenditures	$38.10M
YoY Change	59.41%
Acquisitions
YoY Change
Other Investing Activities	$83.60M
YoY Change	-251.45%
Cash From Investing Activities	$45.50M
YoY Change	-157.52%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$178.5M
YoY Change	222.78%
NET CHANGE
Cash From Operating Activities	-$98.90M
Cash From Investing Activities	$45.50M
Cash From Financing Activities	-$178.5M
Net Change In Cash	-$231.9M
YoY Change	-54.51%
FREE CASH FLOW
Cash From Operating Activities	-$98.90M
Capital Expenditures	$38.10M
Free Cash Flow	-$137.0M
YoY Change	-65.69%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000914208
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-13908
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	Invesco Ltd.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	D0
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-0557567
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	1331 Spring Street,
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 2500,
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Atlanta,
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	GA
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	30309
CY2023Q1	dei	City Area Code CityAreaCode	404
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	892-0896
CY2023Q1	dei	Security12b Title Security12bTitle	Common stock, $0.20 par value
CY2023Q1	dei	Trading Symbol TradingSymbol	IVZ
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	458168885	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	889000000.0	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1234700000	usd
CY2023Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	805700000	usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	801800000	usd
CY2023Q1	us-gaap	Investments Investments	980700000	usd
CY2022Q4	us-gaap	Investments Investments	996600000	usd
CY2023Q1	ivz	Cash And Cash Equivalents Of Consolidated Investment Products CashAndCashEquivalentsOfConsolidatedInvestmentProducts	325900000	usd
CY2022Q4	ivz	Cash And Cash Equivalents Of Consolidated Investment Products CashAndCashEquivalentsOfConsolidatedInvestmentProducts	199400000	usd
CY2023Q1	ivz	Accountsreceivableandotherassetsofconsolidatedinvestmentproducts Accountsreceivableandotherassetsofconsolidatedinvestmentproducts	243800000	usd
CY2022Q4	ivz	Accountsreceivableandotherassetsofconsolidatedinvestmentproducts Accountsreceivableandotherassetsofconsolidatedinvestmentproducts	203700000	usd
CY2023Q1	ivz	Investments Of Consolidated Investment Products InvestmentsOfConsolidatedInvestmentProducts	8551800000	usd
CY2022Q4	ivz	Investments Of Consolidated Investment Products InvestmentsOfConsolidatedInvestmentProducts	8531400000	usd
CY2023Q1	us-gaap	Separate Account Assets SeparateAccountAssets	648500000	usd
CY2022Q4	us-gaap	Separate Account Assets SeparateAccountAssets	668700000	usd
CY2023Q1	us-gaap	Other Assets OtherAssets	981400000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	860500000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	572600000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	561100000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7130800000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7141200000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	8603100000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	8557700000	usd
CY2023Q1	us-gaap	Assets Assets	29733300000	usd
CY2022Q4	us-gaap	Assets Assets	29756800000	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	434700000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	860800000	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	1465800000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	1314800000	usd
CY2023Q1	ivz	Long Term Debt Of Consolidated Investment Products LongTermDebtOfConsolidatedInvestmentProducts	6774300000	usd
CY2022Q4	ivz	Long Term Debt Of Consolidated Investment Products LongTermDebtOfConsolidatedInvestmentProducts	6590400000	usd
CY2023Q1	ivz	Otherliabilitiesofconsolidatedinvestmentproducts Otherliabilitiesofconsolidatedinvestmentproducts	420800000	usd
CY2022Q4	ivz	Otherliabilitiesofconsolidatedinvestmentproducts Otherliabilitiesofconsolidatedinvestmentproducts	329600000	usd
CY2023Q1	us-gaap	Separate Accounts Liability SeparateAccountsLiability	648500000	usd
CY2022Q4	us-gaap	Separate Accounts Liability SeparateAccountsLiability	668700000	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	1488100000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	1487600000	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1691300000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1662700000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	12923500000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	12914600000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	879600000	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	998700000	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.20
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.20
CY2023Q1	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	1000
CY2022Q4	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	1000
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	4000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	4000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	4000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	4000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	4000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	4000000	shares
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	4010500000	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	4010500000	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.20
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.20
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1050000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1050000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	566100000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	566100000	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	113200000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	113200000	usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	7412600000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	7554900000	usd
CY2023Q1	us-gaap	Treasury Stock Value TreasuryStockValue	2888000000	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	3040900000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	7577600000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	7518300000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-882900000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-942400000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	15343000000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	15213600000	usd
CY2023Q1	us-gaap	Minority Interest MinorityInterest	587200000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	629900000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	15930200000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	15843500000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	29733300000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	29756800000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1418200000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1629400000	usd
CY2023Q1	ivz	Third Party Distribution Service And Advisory ThirdPartyDistributionServiceAndAdvisory	455100000	usd
CY2022Q1	ivz	Third Party Distribution Service And Advisory ThirdPartyDistributionServiceAndAdvisory	512600000	usd
CY2023Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	462800000	usd
CY2022Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	432900000	usd
CY2023Q1	us-gaap	Marketing Expense MarketingExpense	25000000.0	usd
CY2022Q1	us-gaap	Marketing Expense MarketingExpense	21700000	usd
CY2023Q1	us-gaap	Communications Information Technology And Occupancy CommunicationsInformationTechnologyAndOccupancy	134400000	usd
CY2022Q1	us-gaap	Communications Information Technology And Occupancy CommunicationsInformationTechnologyAndOccupancy	132000000.0	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	75700000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	102200000	usd
CY2023Q1	ivz	Total Transaction And Integration Charges TotalTransactionAndIntegrationCharges	41600000	usd
CY2022Q1	ivz	Total Transaction And Integration Charges TotalTransactionAndIntegrationCharges	35200000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	14100000	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	15100000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	1208700000	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	1251700000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	209500000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	377700000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	26100000	usd
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	33400000	usd
CY2023Q1	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	8600000	usd
CY2022Q1	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	1200000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	18000000.0	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	23200000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	27400000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-45500000	usd
CY2023Q1	ivz	Other Nonoperating Income Expense Consolidated Investment Products OtherNonoperatingIncomeExpenseConsolidatedInvestmentProducts	-17900000	usd
CY2022Q1	ivz	Other Nonoperating Income Expense Consolidated Investment Products OtherNonoperatingIncomeExpenseConsolidatedInvestmentProducts	-23300000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	235700000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	320300000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	69900000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	82800000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	165800000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	237500000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-38400000	usd
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-19400000	usd
CY2023Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	59200000	usd
CY2022Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	59200000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	145000000.0	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	197700000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.32
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.43
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.32
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.43
CY2023Q1	us-gaap	Profit Loss ProfitLoss	165800000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	237500000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	55100000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-67200000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Other Net Of Tax OtherComprehensiveIncomeOtherNetOfTax	4400000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Other Net Of Tax OtherComprehensiveIncomeOtherNetOfTax	200000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	59500000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-67000000.0	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	225300000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	170500000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-38400000	usd
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-19400000	usd
CY2023Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	59200000	usd
CY2022Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	59200000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	204500000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	130700000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	237500000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	46800000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	49500000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	37800000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	29500000	usd
CY2023Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	27400000	usd
CY2022Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-45500000	usd
CY2023Q1	ivz	Gains And Losses Of Consolidated Investment Products Net GainsAndLossesOfConsolidatedInvestmentProductsNet	-63200000	usd
CY2022Q1	ivz	Gains And Losses Of Consolidated Investment Products Net GainsAndLossesOfConsolidatedInvestmentProductsNet	-55300000	usd
CY2023Q1	ivz	Purchase Of Investments By Consolidated Investment Products PurchaseOfInvestmentsByConsolidatedInvestmentProducts	562600000	usd
CY2022Q1	ivz	Purchase Of Investments By Consolidated Investment Products PurchaseOfInvestmentsByConsolidatedInvestmentProducts	1034200000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	26100000	usd
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	33400000	usd
CY2023Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	2700000	usd
CY2022Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	2800000	usd
CY2023Q1	ivz	Purchasesaleofinvestmentsby Ci Pnet PurchasesaleofinvestmentsbyCIPnet	-32700000	usd
CY2022Q1	ivz	Purchasesaleofinvestmentsby Ci Pnet PurchasesaleofinvestmentsbyCIPnet	127000000.0	usd
CY2023Q1	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	-2900000	usd
CY2022Q1	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	2700000	usd
CY2023Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	70700000	usd
CY2022Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-137700000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-326600000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-770100000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-98900000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-375400000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	38100000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	23900000	usd
CY2023Q1	ivz	Proceeds From Sale Of Investments By Consolidated Investment Products ProceedsFromSaleOfInvestmentsByConsolidatedInvestmentProducts	669500000	usd
CY2022Q1	ivz	Proceeds From Sale Of Investments By Consolidated Investment Products ProceedsFromSaleOfInvestmentsByConsolidatedInvestmentProducts	1019900000	usd
CY2023Q1	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	40700000	usd
CY2022Q1	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	69800000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Other Investments ProceedsFromSaleOfOtherInvestments	21000000.0	usd
CY2022Q1	us-gaap	Proceeds From Sale Of Other Investments ProceedsFromSaleOfOtherInvestments	21200000	usd
CY2023Q1	ivz	Proceeds From Returns Of Capital And Distributions From Equity Method Investments ProceedsFromReturnsOfCapitalAndDistributionsFromEquityMethodInvestments	7000000.0	usd
CY2022Q1	ivz	Proceeds From Returns Of Capital And Distributions From Equity Method Investments ProceedsFromReturnsOfCapitalAndDistributionsFromEquityMethodInvestments	3000000.0	usd
CY2023Q1	ivz	Proceeds From Payments To Consolidation And Deconsolidation Of Subsidiaries ProceedsFromPaymentsToConsolidationAndDeconsolidationOfSubsidiaries	-10600000	usd
CY2022Q1	ivz	Proceeds From Payments To Consolidation And Deconsolidation Of Subsidiaries ProceedsFromPaymentsToConsolidationAndDeconsolidationOfSubsidiaries	4700000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	45500000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-79100000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	27700000	usd
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	232500000	usd
CY2023Q1	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	59200000	usd
CY2022Q1	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	59200000	usd
CY2023Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	85700000	usd
CY2022Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	77800000	usd
CY2023Q1	ivz	Capital Invested Into Consolidated Investment Products CapitalInvestedIntoConsolidatedInvestmentProducts	27500000	usd
CY2022Q1	ivz	Capital Invested Into Consolidated Investment Products CapitalInvestedIntoConsolidatedInvestmentProducts	276800000	usd
CY2023Q1	ivz	Capital Distributed By Consolidated Investment Products CapitalDistributedByConsolidatedInvestmentProducts	67900000	usd
CY2022Q1	ivz	Capital Distributed By Consolidated Investment Products CapitalDistributedByConsolidatedInvestmentProducts	59500000	usd
CY2023Q1	ivz	Proceedsfrom Debt Consolidated Investment Products ProceedsfromDebtConsolidatedInvestmentProducts	39700000	usd
CY2022Q1	ivz	Proceedsfrom Debt Consolidated Investment Products ProceedsfromDebtConsolidatedInvestmentProducts	98300000	usd
CY2023Q1	ivz	Repayments Of Consolidated Investment Products RepaymentsOfConsolidatedInvestmentProducts	5200000	usd
CY2022Q1	ivz	Repayments Of Consolidated Investment Products RepaymentsOfConsolidatedInvestmentProducts	1400000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-178500000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-55300000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-231900000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-509800000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11700000	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-20400000	usd
CY2023Q1	ivz	Effectof Exchange Rateon Cash Cash Equivalents Restricted Cashand Restricted Cash Equivalents Cip EffectofExchangeRateonCashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsCIP	1000000.0	usd
CY2022Q1	ivz	Effectof Exchange Rateon Cash Cash Equivalents Restricted Cashand Restricted Cash Equivalents Cip EffectofExchangeRateonCashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsCIP	-2800000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1434100000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2147100000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1214900000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1614100000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	889000000.0	usd
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1309600000	usd
CY2023Q1	ivz	Cash And Cash Equivalents Of Consolidated Investment Products CashAndCashEquivalentsOfConsolidatedInvestmentProducts	325900000	usd
CY2022Q1	ivz	Cash And Cash Equivalents Of Consolidated Investment Products CashAndCashEquivalentsOfConsolidatedInvestmentProducts	304500000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1214900000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1614100000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	15843500000	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	998700000	usd
CY2023Q1	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	179400000	usd
CY2023Q1	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	-13600000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	59500000	usd
CY2023Q1	ivz	Change In Noncontrolling Interests In Consolidated Entities Net ChangeInNoncontrollingInterestsInConsolidatedEntitiesNet	17900000	usd
CY2023Q1	us-gaap	Temporary Equity Other Changes TemporaryEquityOtherChanges	-105500000	usd
CY2023Q1	us-gaap	Preferred Stock Dividends Per Share Declared PreferredStockDividendsPerShareDeclared	14.75
CY2023Q1	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	59200000	usd
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.1875
CY2023Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	85700000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	37800000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	500000	usd
CY2023Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	27700000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	15930200000	usd
CY2023Q1	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	879600000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	16168000000	usd
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	510800000	usd
CY2022Q1	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	248700000	usd
CY2022Q1	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	-11200000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-67000000.0	usd
CY2022Q1	ivz	Change In Noncontrolling Interests In Consolidated Entities Net ChangeInNoncontrollingInterestsInConsolidatedEntitiesNet	22800000	usd
CY2022Q1	us-gaap	Temporary Equity Other Changes TemporaryEquityOtherChanges	301500000	usd
CY2022Q1	us-gaap	Preferred Stock Dividends Per Share Declared PreferredStockDividendsPerShareDeclared	14.75
CY2022Q1	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	59200000	usd
CY2022Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.17
CY2022Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	79000000.0	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	29500000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	500000	usd
CY2022Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	232500000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	15986200000	usd
CY2022Q1	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	801100000	usd
CY2023Q1	us-gaap	Separate Account Assets SeparateAccountAssets	648500000	usd
CY2023Q1	us-gaap	Derivative Assets DerivativeAssets	11800000	usd
CY2023Q1	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	1401300000	usd
CY2023Q1	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	1300000	usd
CY2022Q4	us-gaap	Separate Account Assets SeparateAccountAssets	668700000	usd
CY2022Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	1754500000	usd
CY2022Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	1600000	usd
CY2022Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	2900000	usd
CY2023Q1	ivz	Foreign Time Deposits ForeignTimeDeposits	25900000	usd
CY2022Q4	ivz	Foreign Time Deposits ForeignTimeDeposits	25700000	usd
CY2023Q1	us-gaap	Equity Method Investments EquityMethodInvestments	658000000	usd
CY2023Q1	us-gaap	Other Investments OtherInvestments	24700000	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	621200000	usd
CY2022Q4	us-gaap	Other Investments OtherInvestments	24700000	usd
CY2023Q1	us-gaap	Equity Method Investments EquityMethodInvestments	658000000.0	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	621200000	usd
CY2023Q1	ivz	Foreign Time Deposits ForeignTimeDeposits	25900000	usd
CY2022Q4	ivz	Foreign Time Deposits ForeignTimeDeposits	25700000	usd
CY2023Q1	us-gaap	Other Investments OtherInvestments	24700000	usd
CY2022Q4	us-gaap	Other Investments OtherInvestments	24700000	usd
CY2023Q1	us-gaap	Investments Investments	980700000	usd
CY2022Q4	us-gaap	Investments Investments	996600000	usd
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	4000000.0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	4000000.0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	4000000.0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	4000000.0	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	566100000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	566100000	shares
CY2023Q1	ivz	Treasury Stock Shares For Which Dividendand Voting Rights Do Not Apply TreasuryStockSharesForWhichDividendandVotingRightsDoNotApply	107900000	shares
CY2022Q4	ivz	Treasury Stock Shares For Which Dividendand Voting Rights Do Not Apply TreasuryStockSharesForWhichDividendandVotingRightsDoNotApply	111300000	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	458200000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	454800000	shares
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	55100000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Other Net Of Tax OtherComprehensiveIncomeOtherNetOfTax	4400000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	59500000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	59500000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-67200000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Other Net Of Tax OtherComprehensiveIncomeOtherNetOfTax	200000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-67000000.0	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-67000000.0	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1418200000	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	186700000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1629400000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	37800000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	29500000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	19.03
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	17.74
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	14.89
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	18.12
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	18.96
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	87300000	usd
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	108300000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	17.74
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	21.24
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y8M8D
CY2023Q1	us-gaap	Restructuring Reserve Period Increase Decrease RestructuringReservePeriodIncreaseDecrease	44300000	usd
CY2022Q1	us-gaap	Restructuring Reserve Period Increase Decrease RestructuringReservePeriodIncreaseDecrease	22300000	usd
CY2022Q4	us-gaap	Restructuring Reserve RestructuringReserve	7100000	usd
CY2021Q4	us-gaap	Restructuring Reserve RestructuringReserve	34800000	usd
CY2023Q1	us-gaap	Restructuring Charges RestructuringCharges	29700000	usd
CY2022	us-gaap	Restructuring Charges RestructuringCharges	13900000	usd
CY2023Q1	us-gaap	Payments For Restructuring PaymentsForRestructuring	3800000	usd
CY2022	us-gaap	Payments For Restructuring PaymentsForRestructuring	41600000	usd
CY2023Q1	us-gaap	Restructuring Reserve RestructuringReserve	33000000.0	usd
CY2022Q4	us-gaap	Restructuring Reserve RestructuringReserve	7100000	usd
CY2023Q1	us-gaap	Restructuring Reserve Settled Without Cash2 RestructuringReserveSettledWithoutCash2	89100000	usd
CY2022	us-gaap	Restructuring Reserve Settled Without Cash2 RestructuringReserveSettledWithoutCash2	74500000	usd
CY2023Q1	us-gaap	Restructuring And Related Cost Cost Incurred To Date1 RestructuringAndRelatedCostCostIncurredToDate1	304800000	usd
CY2022Q4	us-gaap	Restructuring And Related Cost Cost Incurred To Date1 RestructuringAndRelatedCostCostIncurredToDate1	260500000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	145000000.0	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	197700000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	458100000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	459500000	shares
CY2023Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	800000	shares
CY2022Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	2900000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	458900000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	462400000	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.32
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.43
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.32
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.43
CY2023Q1	ivz	Undrawn Capital Commitments UndrawnCapitalCommitments	453000000	usd
CY2022	ivz	Undrawn Capital Commitments UndrawnCapitalCommitments	336100000	usd
CY2023Q1	ivz	Net Interests In Consolidated Investment Products NetInterestsInConsolidatedInvestmentProducts	460300000	usd
CY2022Q4	ivz	Net Interests In Consolidated Investment Products NetInterestsInConsolidatedInvestmentProducts	386600000	usd
CY2023Q1	ivz	Variable Interest Entity Reporting Entity Involvement Unfunded Capital Commitments Amount VariableInterestEntityReportingEntityInvolvementUnfundedCapitalCommitmentsAmount	95500000	usd
CY2022Q4	ivz	Variable Interest Entity Reporting Entity Involvement Unfunded Capital Commitments Amount VariableInterestEntityReportingEntityInvolvementUnfundedCapitalCommitmentsAmount	99000000	usd

Files In Submission

Name	View Source	Status
ivz-20230331_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ivz-20230331_pre.xml	Edgar Link	unprocessable
0000914208-23-000338-index-headers.html	Edgar Link	pending
0000914208-23-000338-index.html	Edgar Link	pending
0000914208-23-000338.txt	Edgar Link	pending
0000914208-23-000338-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_0.jpg	Edgar Link	pending
image_0a.jpg	Edgar Link	pending
image_0c.jpg	Edgar Link	pending
image_1.jpg	Edgar Link	pending
image_1a.jpg	Edgar Link	pending
ivz-20230331.htm	Edgar Link	pending
ivz-20230331.xsd	Edgar Link	pending
ivz-20230331_g1.jpg	Edgar Link	pending
ivz1q2023ex101.htm	Edgar Link	pending
ivz1q2023ex102.htm	Edgar Link	pending
ivz1q2023ex103.htm	Edgar Link	pending
ivz1q2023ex104.htm	Edgar Link	pending
ivz1q2023ex105.htm	Edgar Link	pending
ivz1q2023ex106.htm	Edgar Link	pending
ivz1q2023ex107.htm	Edgar Link	pending
ivz1q2023ex311.htm	Edgar Link	pending
ivz1q2023ex312.htm	Edgar Link	pending
ivz1q2023ex321.htm	Edgar Link	pending
ivz1q2023ex322.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
ivz-20230331_def.xml	Edgar Link	unprocessable
ivz-20230331_lab.xml	Edgar Link	unprocessable
ivz-20230331_htm.xml	Edgar Link	completed
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$IVZ
Invesco Ltd. Stock $ivz

2023 Q1 Form 10-Q Financial Statement

#000091420823000338 Filed on May 03, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IVZ Invesco Ltd. Stock $ivz

2023 Q1 Form 10-Q Financial Statement

#000091420823000338 Filed on May 03, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IVZ
Invesco Ltd. Stock $ivz